Correlation Between Quest PharmaTech and Cingulate
Can any of the company-specific risk be diversified away by investing in both Quest PharmaTech and Cingulate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quest PharmaTech and Cingulate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quest PharmaTech and Cingulate, you can compare the effects of market volatilities on Quest PharmaTech and Cingulate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quest PharmaTech with a short position of Cingulate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quest PharmaTech and Cingulate.
Diversification Opportunities for Quest PharmaTech and Cingulate
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Quest and Cingulate is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quest PharmaTech and Cingulate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate and Quest PharmaTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quest PharmaTech are associated (or correlated) with Cingulate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate has no effect on the direction of Quest PharmaTech i.e., Quest PharmaTech and Cingulate go up and down completely randomly.
Pair Corralation between Quest PharmaTech and Cingulate
Assuming the 90 days horizon Quest PharmaTech is expected to under-perform the Cingulate. But the pink sheet apears to be less risky and, when comparing its historical volatility, Quest PharmaTech is 5.18 times less risky than Cingulate. The pink sheet trades about -0.07 of its potential returns per unit of risk. The Cingulate is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 21,600 in Cingulate on September 14, 2024 and sell it today you would lose (21,178) from holding Cingulate or give up 98.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Quest PharmaTech vs. Cingulate
Performance |
| Timeline |
| Quest PharmaTech |
| Cingulate |
Quest PharmaTech and Cingulate Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quest PharmaTech and Cingulate
The main advantage of trading using opposite Quest PharmaTech and Cingulate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quest PharmaTech position performs unexpectedly, Cingulate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate will offset losses from the drop in Cingulate's long position.| Quest PharmaTech vs. Coya Therapeutics, Common | Quest PharmaTech vs. Cue Biopharma | Quest PharmaTech vs. Lantern Pharma | Quest PharmaTech vs. Fennec Pharmaceuticals |
| Cingulate vs. Puma Biotechnology | Cingulate vs. Iovance Biotherapeutics | Cingulate vs. Day One Biopharmaceuticals | Cingulate vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets |